ATE524459T1 - Pyrazolederivate und ihr einsatz als hemmer von cyclinabhängigen kinasen - Google Patents
Pyrazolederivate und ihr einsatz als hemmer von cyclinabhängigen kinasenInfo
- Publication number
- ATE524459T1 ATE524459T1 AT08857078T AT08857078T ATE524459T1 AT E524459 T1 ATE524459 T1 AT E524459T1 AT 08857078 T AT08857078 T AT 08857078T AT 08857078 T AT08857078 T AT 08857078T AT E524459 T1 ATE524459 T1 AT E524459T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclin
- inhibitors
- pyrazole derivatives
- dependent kinases
- useful
- Prior art date
Links
- 108091007914 CDKs Proteins 0.000 title 1
- 102000003903 Cyclin-dependent kinases Human genes 0.000 title 1
- 108090000266 Cyclin-dependent kinases Proteins 0.000 title 1
- WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical class C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 150000002894 organic compounds Chemical class 0.000 abstract 2
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 230000002062 proliferating effect Effects 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 150000003217 pyrazoles Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1227607P | 2007-12-07 | 2007-12-07 | |
| PCT/EP2008/067037 WO2009071701A1 (en) | 2007-12-07 | 2008-12-08 | Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE524459T1 true ATE524459T1 (de) | 2011-09-15 |
Family
ID=40343520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08857078T ATE524459T1 (de) | 2007-12-07 | 2008-12-08 | Pyrazolederivate und ihr einsatz als hemmer von cyclinabhängigen kinasen |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8367687B2 (de) |
| EP (1) | EP2231636B1 (de) |
| JP (1) | JP2011506303A (de) |
| KR (1) | KR20100098521A (de) |
| CN (1) | CN101883764B (de) |
| AT (1) | ATE524459T1 (de) |
| AU (1) | AU2008333136B2 (de) |
| BR (1) | BRPI0821151A2 (de) |
| CA (1) | CA2707989A1 (de) |
| EA (1) | EA018459B1 (de) |
| ES (1) | ES2374480T3 (de) |
| MX (1) | MX2010006203A (de) |
| PL (1) | PL2231636T3 (de) |
| PT (1) | PT2231636E (de) |
| WO (1) | WO2009071701A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2207775T3 (pl) | 2007-11-05 | 2012-08-31 | Novartis Ag | Pochodne 4-benzyloamino-1-karboksyacylo-piperydyny jako inhibitory CETP użyteczne do leczenia chorób, takich jak hiperlipidemia lub stwardnienie tętnic |
| AU2008333272B2 (en) | 2007-12-03 | 2012-03-29 | Novartis Ag | 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis |
| PE20120325A1 (es) * | 2009-05-19 | 2012-04-12 | Dow Agrosciences Llc | Aminopirimidinas sustituidas con arilo como agentes fungicidas |
| US20130035336A1 (en) * | 2010-04-13 | 2013-02-07 | Novartis Ag | Combination comprising a cyclin dependent kinase 4 or cyclin dependent kinase (cdk4/6) inhibitor for treating cancer |
| AU2011260323A1 (en) | 2010-06-04 | 2012-11-15 | F. Hoffmann-La Roche Ag | Aminopyrimidine derivatives as LRRK2 modulators |
| GB201017345D0 (en) | 2010-10-14 | 2010-11-24 | Proximagen Ltd | Receptor antagonists |
| KR101566091B1 (ko) | 2010-11-10 | 2015-11-04 | 에프. 호프만-라 로슈 아게 | Lrrk2 조절제로서 피라졸 아미노피리미딘 유도체 |
| AU2012232658B2 (en) | 2011-03-22 | 2016-06-09 | Advinus Therapeutics Limited | Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| CA3173988A1 (en) | 2011-10-11 | 2013-04-18 | Dana-Farber Cancer Institute, Inc. | Pyrazol-3-ones that activate pro-apoptotic bax |
| WO2014045305A1 (en) | 2012-09-21 | 2014-03-27 | Advinus Therapeutics Limited | Substituted fused tricyclic compounds, compositions and medicinal applications thereof |
| PH12015501130B1 (en) | 2012-11-21 | 2023-01-27 | Ptc Therapeutics Inc | Substituted reverse pyrimidine bmi-1 inhibitors |
| MX370588B (es) * | 2013-08-30 | 2019-12-16 | Ptc Therapeutics Inc | Inhibidores de la bmi-1 de pirimidina sustituida. |
| US10584115B2 (en) | 2013-11-21 | 2020-03-10 | Ptc Therapeutics, Inc. | Substituted pyridine and pyrazine BMI-1 inhibitors |
| JP6927882B2 (ja) | 2015-04-02 | 2021-09-01 | プロキシマジェン，リミティド ライアビリティ カンパニー | 癌の新治療法 |
| RS62728B1 (sr) * | 2015-08-04 | 2022-01-31 | Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd | Derivat pirazol pirimidina i njegove upotrebe |
| CR20200464A (es) | 2018-03-08 | 2021-04-14 | Incyte Corp | Compuestos diólicos de aminopirazina como inhibidores de pi3k-y |
| WO2020010003A1 (en) | 2018-07-02 | 2020-01-09 | Incyte Corporation | AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS |
| JP2021535198A (ja) | 2018-08-17 | 2021-12-16 | ピーティーシー セラピューティクス， インコーポレイテッド | 膵臓癌を治療する方法 |
| US11066404B2 (en) | 2018-10-11 | 2021-07-20 | Incyte Corporation | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors |
| WO2020168197A1 (en) | 2019-02-15 | 2020-08-20 | Incyte Corporation | Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors |
| TW202100520A (zh) * | 2019-03-05 | 2021-01-01 | 美商英塞特公司 | 作為cdk2 抑制劑之吡唑基嘧啶基胺化合物 |
| US11919904B2 (en) | 2019-03-29 | 2024-03-05 | Incyte Corporation | Sulfonylamide compounds as CDK2 inhibitors |
| WO2020223558A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | Tricyclic amine compounds as cdk2 inhibitors |
| WO2020223469A1 (en) | 2019-05-01 | 2020-11-05 | Incyte Corporation | N-(1-(methylsulfonyl)piperidin-4-yl)-4,5-di hydro-1h-imidazo[4,5-h]quinazolin-8-amine derivatives and related compounds as cyclin-dependent kinase 2 (cdk2) inhibitors for treating cancer |
| WO2021030537A1 (en) | 2019-08-14 | 2021-02-18 | Incyte Corporation | Imidazolyl pyrimidinylamine compounds as cdk2 inhibitors |
| CR20220170A (es) | 2019-10-11 | 2022-10-10 | Incyte Corp | Aminas bicíclicas como inhibidoras de la cdk2 |
| US11981671B2 (en) | 2021-06-21 | 2024-05-14 | Incyte Corporation | Bicyclic pyrazolyl amines as CDK2 inhibitors |
| TW202329937A (zh) | 2021-12-03 | 2023-08-01 | 美商英塞特公司 | 雙環胺ｃｋ１２抑制劑 |
| US12084453B2 (en) | 2021-12-10 | 2024-09-10 | Incyte Corporation | Bicyclic amines as CDK12 inhibitors |
| US11976073B2 (en) | 2021-12-10 | 2024-05-07 | Incyte Corporation | Bicyclic amines as CDK2 inhibitors |
| EP4725942A1 (de) * | 2024-10-09 | 2026-04-15 | Sibylla Biotech S.p.A. | Verbindungen mit wirkung auf den cyclin-d1-pfad und ihre verwendung |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6979686B1 (en) | 2001-12-07 | 2005-12-27 | Pharmacia Corporation | Substituted pyrazoles as p38 kinase inhibitors |
| GB9919778D0 (en) * | 1999-08-21 | 1999-10-27 | Zeneca Ltd | Chemical compounds |
| CA2430539C (en) | 2000-12-05 | 2010-07-13 | Vertex Pharmaceuticals Incorporated | Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| GB0107901D0 (en) * | 2001-03-29 | 2001-05-23 | Cyclacel Ltd | Anti-cancer compounds |
| JP4316893B2 (ja) * | 2001-05-16 | 2009-08-19 | バーテックス ファーマシューティカルズ インコーポレイテッド | Ｓｒｃおよび他のプロテインキナーゼのインヒビター |
| WO2003051886A1 (en) | 2001-12-17 | 2003-06-26 | Smithkline Beecham Corporation | Pyrazolopyridazine derivatives |
| GB0215844D0 (en) | 2002-07-09 | 2002-08-14 | Novartis Ag | Organic compounds |
| WO2004035588A1 (en) | 2002-10-15 | 2004-04-29 | Smithkline Beecham Corporation | Pyradazine compounds as gsk-3 inhibitors |
| GB0409080D0 (en) * | 2004-04-23 | 2004-05-26 | Biofocus Discovery Ltd | Compounds which interact with protein kinases |
| EP1917258A2 (de) | 2005-08-26 | 2008-05-07 | SmithKline Beecham Corporation | Pyrimidinyl-pyrazol-hemmer von aurora-kinasen |
| EA200802050A1 (ru) * | 2006-04-19 | 2009-04-28 | Лаборатуар Сероно Са | Новые гетероарилзамещенные ариламинопиридиновые производные в качестве мек ингибиторов |
| WO2007132220A1 (en) | 2006-05-12 | 2007-11-22 | Cyclacel Limited | Combination of a 2-substituted-4-heter0aryl-pyrimidine amine with a cytotoxic drug and use thereof in the treatment of a proliferative disorder |
| US20100144756A1 (en) * | 2007-07-13 | 2010-06-10 | Bolea Christelle | Novel heteroaromatic derivatives and their use as positive allosteric modulators of metabotropic glutamate receptors |
-
2008
- 2008-12-08 EP EP08857078A patent/EP2231636B1/de not_active Not-in-force
- 2008-12-08 CA CA2707989A patent/CA2707989A1/en not_active Abandoned
- 2008-12-08 EA EA201000879A patent/EA018459B1/ru not_active IP Right Cessation
- 2008-12-08 WO PCT/EP2008/067037 patent/WO2009071701A1/en not_active Ceased
- 2008-12-08 BR BRPI0821151-5A patent/BRPI0821151A2/pt not_active IP Right Cessation
- 2008-12-08 PT PT08857078T patent/PT2231636E/pt unknown
- 2008-12-08 PL PL08857078T patent/PL2231636T3/pl unknown
- 2008-12-08 AU AU2008333136A patent/AU2008333136B2/en not_active Ceased
- 2008-12-08 KR KR1020107012317A patent/KR20100098521A/ko not_active Ceased
- 2008-12-08 AT AT08857078T patent/ATE524459T1/de active
- 2008-12-08 CN CN2008801187516A patent/CN101883764B/zh not_active Expired - Fee Related
- 2008-12-08 MX MX2010006203A patent/MX2010006203A/es active IP Right Grant
- 2008-12-08 JP JP2010536492A patent/JP2011506303A/ja active Pending
- 2008-12-08 US US12/746,265 patent/US8367687B2/en not_active Expired - Fee Related
- 2008-12-08 ES ES08857078T patent/ES2374480T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009071701A1 (en) | 2009-06-11 |
| AU2008333136A1 (en) | 2009-06-11 |
| AU2008333136B2 (en) | 2012-05-10 |
| CN101883764B (zh) | 2013-11-13 |
| EP2231636B1 (de) | 2011-09-14 |
| KR20100098521A (ko) | 2010-09-07 |
| CA2707989A1 (en) | 2009-06-11 |
| CN101883764A (zh) | 2010-11-10 |
| BRPI0821151A2 (pt) | 2015-06-16 |
| MX2010006203A (es) | 2010-06-25 |
| US8367687B2 (en) | 2013-02-05 |
| EA201000879A1 (ru) | 2010-12-30 |
| EP2231636A1 (de) | 2010-09-29 |
| PT2231636E (pt) | 2012-01-02 |
| ES2374480T3 (es) | 2012-02-17 |
| JP2011506303A (ja) | 2011-03-03 |
| US20100280033A1 (en) | 2010-11-04 |
| EA018459B1 (ru) | 2013-08-30 |
| PL2231636T3 (pl) | 2012-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0821151A2 (pt) | Derivados de pirazol e uso dos mesmos como inibidores de quinases dependentes de ciclina | |
| JO3235B1 (ar) | مركبات بيررولوبيريميدين و استعمالاتها | |
| EA200900798A1 (ru) | Производные индол-4-илпиримидинил-2-иламина и их применение в качестве ингибиторов циклинзависимой киназы | |
| MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
| EA200970738A1 (ru) | Ингибиторы активности akt | |
| EA200900819A1 (ru) | Хиназолины для ингибирования pdk1 | |
| TNSN08400A1 (en) | Organic compounds and their uses | |
| EA201101477A1 (ru) | Органические соединения и их применение | |
| UA107783C2 (en) | Isoindoline compounds for use in treating cancer | |
| EA200900571A1 (ru) | Композиции chk1 ингибиторов | |
| ECSP099414A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteína quinasa | |
| NO20092658L (no) | New compounds | |
| EA200901144A1 (ru) | Ингибиторы киназы pim и способы их применения | |
| ATE516286T1 (de) | 5-(ä1,3,4üoxadiazol-2-yl)-1h-indazol und 5-(ä1,3, 4üthiadiazol-2-yl)-1h-indazol derivate als sgk- inhibitoren zur behandlung von diabetes | |
| TW200801008A (en) | Protein kinase inhibitors | |
| EA200800441A1 (ru) | Замещенные бензимидазолы в качестве ингибиторов киназ | |
| EA201200323A1 (ru) | Соединения и композиции, как ингибиторы протеинкиназы | |
| ATE502944T1 (de) | 2-amino-5,7-dihydro-6h-pyrroloä3,4- düpyrimidinderivate als hsp-90-inhibitoren zur behandlung von krebs | |
| WO2008063558A3 (en) | Combination of an inhibitor of dna polymerase-alpha and an inhibitor of a checkpoint kinase for proliferative disorders | |
| TNSN08496A1 (en) | Aminothiazoles and their uses | |
| WO2007016338A3 (en) | Use of chk2 kinase inhibitors for cancer treatment | |
| BR112013009260A2 (pt) | compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase | |
| TN2009000495A1 (en) | Macrocycles and their uses | |
| EA200971067A1 (ru) | Триазолиламинопиримидиновые соединения | |
| ATE527264T1 (de) | Kondensierte heterozyklische verbindungen als hemmer von proteinkinasen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 2231636 Country of ref document: EP |